Literature DB >> 6603310

Enkephalins--enhancement of active T-cell rosettes from lymphoma patients.

G C Miller, A J Murgo, N P Plotnikoff.   

Abstract

Methionine enkephalin was found to increase significantly the active T-cell rosettes from lymphoma patients. In sharp contrast, the leucine enkephalin was observed to increase active rosettes only at a single low concentration. Neither enkephalin significantly altered the total T-cell rosettes. It is suggested that methionine enkephalin could have a significant influence in enhancing cell-mediated immunity and T-cell function, particularly in lymphoma patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603310     DOI: 10.1016/0090-1229(83)90131-9

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  6 in total

Review 1.  Invertebrate and vertebrate neuroimmune and autoimmunoregulatory commonalties involving opioid peptides.

Authors:  G B Stefano
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

2.  Bidirectional effect of met-enkephalin on macrophage effector functions.

Authors:  G Fóris; G A Medgyesi; M Hauck
Journal:  Mol Cell Biochem       Date:  1986-02       Impact factor: 3.396

3.  Methionine-enkephalin as immunomodulator therapy in human immunodeficiency virus infections: clinical and immunological effects.

Authors:  K M Zunich; C H Kirkpatrick
Journal:  J Clin Immunol       Date:  1988-03       Impact factor: 8.317

4.  Normotensive pheochromocytoma.

Authors:  A J Murgo
Journal:  West J Med       Date:  1984-01

5.  The effect of chronic treatment with naltrindole, a selective delta-opioid antagonist, on mu-opioid receptor-mediated antinociception in diabetic mice.

Authors:  J Kamei; N Kawashima; Y Iwamoto; T Suzuki; H Nagase; M Misawa; Y Kasuya
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Evaluation of BW942C, a novel antidiarrheal agent, against enterotoxins of Escherichia coli and Vibrio cholerae.

Authors:  D R Morgan; J Sellin; L Gutierrez; H L DuPont; L V Wood
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.